HALOZYME THERAPEUTICS INC 4
4 · HALOZYME THERAPEUTICS INC · Filed Dec 11, 2013
Insider Transaction Report
Form 4
Frost Gregory Ian
DirectorVP and Chief Scientific Off.
Transactions
- Exercise/Conversion
Common Stock
2013-12-11$2.02/sh+6,467$13,063→ 3,608,267 total - Exercise/Conversion
Option to Purchase Common Stock (ISO)
2013-12-11−6,467→ 0 totalExercise: $2.02From: 2004-12-08Exp: 2014-12-08→ Common Stock (6,467 underlying) - Exercise/Conversion
Option to Purchase Common Stock (NSO)
2013-12-11−10,420→ 34,864 totalExercise: $2.02From: 2004-12-08Exp: 2014-12-08→ Common Stock (10,420 underlying) - Exercise/Conversion
Common Stock
2013-12-11$2.02/sh+10,420$21,048→ 3,601,800 total - Exercise/Conversion
Common Stock
2013-12-11$2.05/sh+33,113$67,882→ 3,641,380 total - Exercise/Conversion
Option to Purchase Common Stock (ISO)
2013-12-11−33,113→ 667 totalExercise: $2.05From: 2008-02-02Exp: 2014-10-13→ Common Stock (33,113 underlying)